b 669 has been researched along with lysophosphatidylcholines in 3 studies
Studies (b 669) | Trials (b 669) | Recent Studies (post-2010) (b 669) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
---|---|---|---|---|---|
16 | 0 | 0 | 5,058 | 39 | 976 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, R; Van Rensburg, CE; Van Staden, AM | 1 |
Anderson, R; Prinsloo, Y; van der Walt, R; van Rensburg, CE | 1 |
Anderson, R; De Bruyn, EE; Steel, HC; Van Rensburg, EJ | 1 |
3 other study(ies) available for b 669 and lysophosphatidylcholines
Article | Year |
---|---|
The riminophenazine agents clofazimine and B669 inhibit the proliferation of cancer cell lines in vitro by phospholipase A2-mediated oxidative and nonoxidative mechanisms.
Topics: Animals; Arachidonic Acid; Bleomycin; Cell Death; Cell Division; Cisplatin; Clofazimine; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Growth Inhibitors; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Methotrexate; Neutrophils; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Protein Kinase C; Tumor Cells, Cultured; Vitamin E | 1993 |
Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.
Topics: Adenosine Triphosphate; Adult; Arachidonic Acid; Clofazimine; Cyclosporine; Drug Synergism; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lysophosphatidylcholines; Sodium-Potassium-Exchanging ATPase | 1995 |
The riminophenazines, clofazimine and B669, inhibit potassium transport in gram-positive bacteria by a lysophospholipid-dependent mechanism.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Biological Transport; Clofazimine; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Lysophosphatidylcholines; Lysophospholipids; Mutation; Potassium; Potassium Radioisotopes; Rubidium Radioisotopes; Vitamin E | 1996 |